JP2011523405A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523405A5
JP2011523405A5 JP2011508703A JP2011508703A JP2011523405A5 JP 2011523405 A5 JP2011523405 A5 JP 2011523405A5 JP 2011508703 A JP2011508703 A JP 2011508703A JP 2011508703 A JP2011508703 A JP 2011508703A JP 2011523405 A5 JP2011523405 A5 JP 2011523405A5
Authority
JP
Japan
Prior art keywords
igf
variable domain
drug
immunoglobulin variable
chain immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508703A
Other languages
English (en)
Japanese (ja)
Other versions
JP5734180B2 (ja
JP2011523405A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/043273 external-priority patent/WO2009137758A2/en
Publication of JP2011523405A publication Critical patent/JP2011523405A/ja
Publication of JP2011523405A5 publication Critical patent/JP2011523405A5/ja
Application granted granted Critical
Publication of JP5734180B2 publication Critical patent/JP5734180B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508703A 2008-05-09 2009-05-08 Igf−ii/igf−iie結合タンパク質 Expired - Fee Related JP5734180B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US5195608P 2008-05-09 2008-05-09
US61/051,956 2008-05-09
US5342708P 2008-05-15 2008-05-15
US61/053,427 2008-05-15
US16318009P 2009-03-25 2009-03-25
US61/163,180 2009-03-25
PCT/US2009/043273 WO2009137758A2 (en) 2008-05-09 2009-05-08 Igf-ii/gf-iie binding proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014016462A Division JP2014077020A (ja) 2008-05-09 2014-01-31 Igf−ii/igf−iie結合タンパク質

Publications (3)

Publication Number Publication Date
JP2011523405A JP2011523405A (ja) 2011-08-11
JP2011523405A5 true JP2011523405A5 (https=) 2013-04-11
JP5734180B2 JP5734180B2 (ja) 2015-06-17

Family

ID=41265434

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011508703A Expired - Fee Related JP5734180B2 (ja) 2008-05-09 2009-05-08 Igf−ii/igf−iie結合タンパク質
JP2014016462A Pending JP2014077020A (ja) 2008-05-09 2014-01-31 Igf−ii/igf−iie結合タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014016462A Pending JP2014077020A (ja) 2008-05-09 2014-01-31 Igf−ii/igf−iie結合タンパク質

Country Status (6)

Country Link
US (1) US20110165145A1 (https=)
EP (1) EP2296703A4 (https=)
JP (2) JP5734180B2 (https=)
AU (1) AU2009244091B2 (https=)
CA (1) CA2723722A1 (https=)
WO (1) WO2009137758A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090368A1 (es) 2007-06-19 2009-04-28 Boehringer Ingelheim Int Anticuerpos anti-igf
US20110262446A1 (en) * 2008-10-14 2011-10-27 Dyax Corp. Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
NZ592151A (en) 2008-12-12 2012-10-26 Boehringer Ingelheim Int Anti-igf antibodies
US9150644B2 (en) 2011-04-12 2015-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
US20140255413A1 (en) 2013-03-07 2014-09-11 Boehringer Ingelheim International Gmbh Combination therapy for neoplasia treatment
KR101843248B1 (ko) * 2015-03-17 2018-03-29 고려대학교 세종산학협력단 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물
US10469309B1 (en) * 2016-04-28 2019-11-05 Servicenow, Inc. Management of computing system alerts

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058041A1 (en) 1990-06-27 1991-12-28 Katsuichi Sakano Anti-igf-ii monoclonal antibody
JP3213359B2 (ja) * 1990-12-21 2001-10-02 第一製薬株式会社 抗igf−iiモノクローナル抗体
JP4335130B2 (ja) * 2002-04-30 2009-09-30 協和発酵キリン株式会社 ヒトインスリン様成長因子に対する抗体
WO2005018671A1 (ja) * 2003-08-21 2005-03-03 Kyowa Hakko Kogyo Co., Ltd. 癌転移阻害剤
WO2005027970A1 (ja) * 2003-09-24 2005-03-31 Kyowa Hakko Kogyo Co., Ltd. 癌治療用医薬
EP1676862B1 (en) * 2003-09-24 2010-12-22 Kyowa Hakko Kirin Co., Ltd. Recombinant antibody against human insulin-like growth factor
US7612179B2 (en) * 2003-11-28 2009-11-03 Astrazeneca Ab antibodies binding to a C-terminal fragment of apoliopoprotein E
JP5054385B2 (ja) * 2004-02-19 2012-10-24 ダイアックス、コープ 立体配座特異的抗体
CA2575791A1 (en) * 2004-08-03 2006-02-16 Dyax Corp. Hk1-binding proteins
CA2618920C (en) 2005-08-17 2015-03-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human monoclonal antibodies that specifically bind igf-ii
ES2385054T3 (es) * 2005-12-13 2012-07-17 Medimmune Limited Proteínas de unión específicas para factores de crecimiento de tipo insulina y usos de las mismas
KR20090029184A (ko) * 2006-04-07 2009-03-20 더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 항체 조성물 및 신생물성 질병의 치료 방법
WO2008144720A2 (en) * 2007-05-21 2008-11-27 University Of Washington Inhibitors of igf-1r signaling for the treatment of respiratory disorders

Similar Documents

Publication Publication Date Title
JP2011523405A5 (https=)
JP2023061927A5 (https=)
TWI354561B (en) Pharmaceutical compositions and uses for treatment
JP2004532817A5 (https=)
Zandi et al. Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model
JP2012100677A5 (https=)
JP2005533001A5 (https=)
JP2010526028A5 (https=)
JP2018529634A5 (https=)
JP2006516639A5 (https=)
RU2012156938A (ru) Антитела против gdf8 человека
JP2016509585A5 (https=)
JP2006522830A5 (https=)
JP2006516116A5 (https=)
NO20083793L (no) Antistoffer mot amyloid-beta peptid
CN105358175B (zh) 用于治疗硬皮病的抗ccl2和抗loxl2组合疗法
SI3064511T1 (en) THE MEDICINE USE OF HUMAN HIGHLIGHTS FOR HUMAN RECEPTOR IL-4
RU2014105496A (ru) Способы снижения числа эозинофилов
JP2009539841A5 (https=)
RU2018100129A (ru) Способы лечения подагры
JP2009511480A5 (https=)
JP2010531140A5 (https=)
JP2014500278A (ja) 二重特異性scFvコンジュゲートの投薬量および投与
JP2017113019A5 (https=)
JP2019509054A5 (https=)